BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29209566)

  • 1. Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway.
    Shen Y; Guo D; Weng L; Wang S; Ma Z; Yang Y; Wang P; Wang J; Cai Z
    Oncoimmunology; 2017; 6(12):e1362527. PubMed ID: 29209566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
    Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
    J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes Derived from Heat-shocked Tumor Cells Promote In vitro Maturation of Bone Marrow-derived Dendritic Cells.
    Heidari N; Abbasi-Kenarsari H; Niknam B; Asadirad A; Amani D; Mirsanei Z; Hashemi SM
    Iran J Allergy Asthma Immunol; 2024 Feb; 23(1):97-106. PubMed ID: 38485913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
    Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
    Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.
    Liu H; Chen L; Peng Y; Yu S; Liu J; Wu L; Zhang L; Wu Q; Chang X; Yu X; Liu T
    Oncotarget; 2018 Jan; 9(2):2887-2894. PubMed ID: 29416821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
    Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
    Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203.
    Zhou M; Chen J; Zhou L; Chen W; Ding G; Cao L
    Cell Immunol; 2014; 292(1-2):65-9. PubMed ID: 25290620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
    Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
    Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
    Huang F; Wan J; Hu W; Hao S
    Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA modified tumor-derived exosomes as novel tools for maturation of dendritic cells.
    Taghikhani A; Hassan ZM; Ebrahimi M; Moazzeni SM
    J Cell Physiol; 2019 Jun; 234(6):9417-9427. PubMed ID: 30362582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes.
    Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G
    Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer.
    Verdi J; Ketabchi N; Noorbakhsh N; Saleh M; Ebrahimi-Barough S; Seyhoun I; Kavianpour M
    Curr Stem Cell Res Ther; 2022; 17(1):91-102. PubMed ID: 34161212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomagnetic capture and traceless release of native tumor-derived exosomes from human plasma for exploring interaction with recipient cells by aptamer-functionalized nanoflowers.
    Zheng H; Su N; Yan G; Li M; Chu H; Zhang J; Li B; Zhao J; Wang J; Gao M; Zhang X
    Anal Chim Acta; 2024 Jan; 1287():342109. PubMed ID: 38182386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target-induced proximity ligation triggers recombinase polymerase amplification and transcription-mediated amplification to detect tumor-derived exosomes in nasopharyngeal carcinoma with high sensitivity.
    Liu W; Li J; Wu Y; Xing S; Lai Y; Zhang G
    Biosens Bioelectron; 2018 Apr; 102():204-210. PubMed ID: 29145073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
    Okada S; Han S; Patel ES; Yang LJ; Chang LJ
    Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.
    Chen W; Jiang J; Xia W; Huang J
    J Immunol Res; 2017; 2017():1073947. PubMed ID: 28642882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of immunotherapy based on dendritic cells stimulated by tumor cell-derived exosomes in a syngeneic breast tumor mouse model.
    Piao YJ; Yoon SH; Kim HS; Moon WK; Han W
    Biochem Biophys Rep; 2021 Dec; 28():101136. PubMed ID: 34646949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of the dendritic cell response triggered by different serotypes of Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis is toll-like receptor 2 (TLR2) or TLR4 dependent.
    Díaz-Zúñiga J; Monasterio G; Alvarez C; Melgar-Rodríguez S; Benítez A; Ciuchi P; García M; Arias J; Sanz M; Vernal R
    J Periodontol; 2015 Jan; 86(1):108-19. PubMed ID: 25224175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway.
    Rizzuti D; Ang M; Sokollik C; Wu T; Abdullah M; Greenfield L; Fattouh R; Reardon C; Tang M; Diao J; Schindler C; Cattral M; Jones NL
    J Innate Immun; 2015; 7(2):199-211. PubMed ID: 25412627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo.
    Guan S; Li Q; Liu P; Xuan X; Du Y
    Cent Eur J Immunol; 2014; 39(2):142-51. PubMed ID: 26155115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.